- Home
- ARVN vs TOI Comparison
ARVN vs TOI Comparison
Compare ARVN & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- TOI
- Stock Information
- Founded
- ARVN 2015
- TOI 2007
- Country
- ARVN United States
- TOI United States
- Employees
- ARVN N/A
- TOI N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- ARVN Health Care
- TOI Health Care
- Exchange
- ARVN Nasdaq
- TOI Nasdaq
- Market Cap
- ARVN 456.2M
- TOI 393.4M
- IPO Year
- ARVN 2018
- TOI N/A
- Fundamental
- Price
- ARVN $7.61
- TOI $2.99
- Analyst Decision
- ARVN Buy
- TOI Strong Buy
- Analyst Count
- ARVN 22
- TOI 1
- Target Price
- ARVN $20.02
- TOI $6.00
- AVG Volume (30 Days)
- ARVN 1.3M
- TOI 1.4M
- Earning Date
- ARVN 10-29-2025
- TOI 11-12-2025
- Dividend Yield
- ARVN N/A
- TOI N/A
- EPS Growth
- ARVN N/A
- TOI N/A
- EPS
- ARVN N/A
- TOI N/A
- Revenue
- ARVN $372,800,000.00
- TOI $424,376,000.00
- Revenue This Year
- ARVN $1.61
- TOI $21.96
- Revenue Next Year
- ARVN N/A
- TOI $20.34
- P/E Ratio
- ARVN N/A
- TOI N/A
- Revenue Growth
- ARVN 299.57
- TOI 17.53
- 52 Week Low
- ARVN $5.90
- TOI $0.13
- 52 Week High
- ARVN $29.61
- TOI $4.50
- Technical
- Relative Strength Index (RSI)
- ARVN 49.90
- TOI 34.60
- Support Level
- ARVN $7.58
- TOI $2.98
- Resistance Level
- ARVN $7.89
- TOI $3.18
- Average True Range (ATR)
- ARVN 0.37
- TOI 0.18
- MACD
- ARVN -0.03
- TOI -0.04
- Stochastic Oscillator
- ARVN 18.42
- TOI 7.08
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.